Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
OSI Systems
OSIS
$3.87B
| $20.4M | 0.01% |
202,099
+53,905
| +36% | +$5.33M |
|
|
TSE
1202
DELISTED
Trinseo
TSE
| $20.3M | 0.01% |
546,751
-6,011
| -1% | -$244K |
|
|
ICPT
1203
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $20.3M | 0.01% |
163,811
+3,125
| +2% | +$280K |
|
1204
Myriad Genetics
MYGN
$302M
| $20.3M | 0.01% |
745,343
+3,641
| +0.5% | +$100K |
|
1205
Simmons First National
SFNC
$3.43B
| $20.3M | 0.01% |
756,142
+111,742
| +17% | +$2.82M |
|
1206
Iovance Biotherapeutics
IOVA
$2.89B
| $20.2M | 0.01% |
729,497
+28,564
| +4% | +$650K |
|
|
ADSW
1207
DELISTED
Advanced Disposal Services Inc
ADSW
| $20.2M | 0.01% |
614,243
+14,927
| +2% | +$490K |
|
|
CVSA
1208
Covista Inc
CVSA
$4.41B
| $20.2M | 0.01% |
576,846
+21,199
| +4% | +$730K |
|
1209
TAL Education Group
TAL
$6.81B
| $20.2M | 0.01% |
418,290
+6,149
| +1% | +$264K |
|
1210
Westlake Corp
WLK
$10.3B
| $20.1M | 0.01% |
286,857
+10,716
| +4% | +$720K |
|
1211
Protolabs
PRLB
$2.17B
| $20.1M | 0.01% |
197,571
+10,004
| +5% | +$991K |
|
1212
Cheesecake Factory
CAKE
$5.63B
| $20M | 0.01% |
514,368
+19,993
| +4% | +$824K |
|
1213
Independent Bank
INDB
$4.01B
| $20M | 0.01% |
240,066
+12,180
| +5% | +$996K |
|
|
PEGI
1214
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $20M | 0.01% |
746,913
+17,604
| +2% | +$478K |
|
1215
NeoGenomics
NEO
$2.13B
| $20M | 0.01% |
682,537
+15,873
| +2% | +$378K |
|
1216
Fabrinet
FN
$18.9B
| $19.8M | 0.01% |
306,069
+9,011
| +3% | +$521K |
|
1217
Outfront Media
OUT
$5.31B
| $19.8M | 0.01% |
751,677
+13,834
| +2% | +$356K |
|
1218
Hain Celestial
HAIN
$53M
| $19.8M | 0.01% |
764,149
+19,312
| +3% | +$461K |
|
1219
Pegasystems
PEGA
$5.37B
| $19.8M | 0.01% |
497,520
+11,310
| +2% | +$428K |
|
|
WPG
1220
DELISTED
Washington Prime Group Inc.
WPG
| $19.8M | 0.01% |
604,170
+41,074
| +7% | +$1.49M |
|
1221
Medpace
MEDP
$16.8B
| $19.8M | 0.01% |
235,185
+6,290
| +3% | +$487K |
|
1222
WD-40
WDFC
$3.15B
| $19.7M | 0.01% |
101,555
+1,620
| +2% | +$305K |
|
|
TRTN
1223
DELISTED
Triton International Limited
TRTN
| $19.7M | 0.01% |
489,557
+4,323
| +0.9% | +$160K |
|
1224
Northwest Bancshares
NWBI
$2.28B
| $19.7M | 0.01% |
1,183,249
+10,070
| +0.9% | +$168K |
|
1225
CNX Resources
CNX
$5.29B
| $19.6M | 0.01% |
2,217,073
+95,808
| +5% | +$747K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.